Sun Pharma's Nidlegy™ Marketing Application Accepted by EMA for Skin Cancer Treatment
July 4, 2024, 12:38 p.m.
Sun Pharmaceutical Industries Limited announced that the European Medicines Agency (EMA) has validated the submission of the Marketing Authorisation Application (MAA) for Nidlegy™.
Th…
Unlock the Full Filing And Lot More
Access premium insights and stay ahead of the market with Dzambhala Pro.